Becton, Dickinson and Company (BDXA) Financial Analysis & Valuation | Quarter Chart
Becton, Dickinson and Company (BDXA)
BDXAPrice: $59.24
Fair Value: 🔒
🔒score
Description
Shares
| Market Cap | $55.91B | Exchange | NYSE |
| Sector | Healthcare | Industry | Medical - Instruments & Supplies |
| Country | — | CEO | — |
| IPO Date | 2017-05-11 | CAGR | 0.08% |
| Employees | — | Website | — |
| Div. Yield | 2.38% | Payout Ratio | 1.04% |
| Buy Back Yield | 0.45% | Total Yield | 2.83% |
BDXA chart loading...
Fundamentals
Technicals
| Enterprise Value | $60.59B | P/E Ratio | 21.44 |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | 2.5 | P/B Ratio | 1.72 |
| P/CF Ratio | 10.62 | P/FCF Ratio | 17.02 |
| EPS | $2.76 | EPS Growth 1Y | -24.62% |
| EPS Growth 3Y | -25.89% | EPS Growth 5Y | -29.72% |
| Revenue Growth 1Y | 2.39% | Gross Margin | 0.46% |
| Operating Margin | 0.11% | Profit Margin | 0.05% |
| ROE | 0.05% | ROA | 0.02% |
| ROCE | 0.05% | Current Ratio | 0.94 |
| Quick Ratio | 0.55 | Cash Ratio | 0.1 |
| Debt/Equity | 0.72 | Interest Coverage | 4.03 |
| Altman Z Score | 2.12 | Piotroski Score | 8 |